The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(cyclopropyl(3-methylpyridin-2-yl)methyl)-5-fluoro-7-methyl-1H-indole-2-carboxamide ID: ALA5088823
PubChem CID: 166632318
Max Phase: Preclinical
Molecular Formula: C20H20FN3O
Molecular Weight: 337.40
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccnc1C(NC(=O)c1cc2cc(F)cc(C)c2[nH]1)C1CC1
Standard InChI: InChI=1S/C20H20FN3O/c1-11-4-3-7-22-18(11)19(13-5-6-13)24-20(25)16-10-14-9-15(21)8-12(2)17(14)23-16/h3-4,7-10,13,19,23H,5-6H2,1-2H3,(H,24,25)
Standard InChI Key: QIDFIJWFEVSKGM-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
1.3028 -10.3965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3016 -11.2160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0097 -11.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0079 -9.9876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7165 -10.3929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7213 -11.2115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5013 -11.4599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9787 -10.7948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4936 -10.1354 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0055 -9.1704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7959 -10.7900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2086 -11.4953 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2003 -10.0799 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0175 -10.0751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4219 -9.3649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4302 -10.7803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4351 -11.5975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1404 -11.1847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2399 -9.3628 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6442 -8.6535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2314 -7.9473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4100 -7.9547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0094 -8.6646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1922 -8.6721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5936 -11.6240 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
4 10 1 0
8 11 1 0
11 12 2 0
11 13 1 0
13 14 1 0
14 15 1 0
14 16 1 0
17 16 1 0
18 17 1 0
16 18 1 0
15 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 15 1 0
23 24 1 0
2 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 337.40Molecular Weight (Monoisotopic): 337.1590AlogP: 4.20#Rotatable Bonds: 4Polar Surface Area: 57.78Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.57CX LogP: 3.82CX LogD: 3.82Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.75Np Likeness Score: -1.27
References 1. Lampe JW, Alford JS, Boriak-Sjodin PA, Brach D, Cosmopoulos K, Duncan KW, Eckley ST, Foley MA, Harvey DM, Motwani V, Munchhof MJ, Raimondi A, Riera TV, Tang C, Thomenius MJ, Totman J, Farrow NA.. (2021) Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies., 12 (10.0): [PMID:34671445 ] [10.1021/acsmedchemlett.1c00272 ]